Age at diagnosis (±SD) (years) | 74.8 ± 6.3 |
Initial PSA (ng/mL) | 537.3 ± 999 (median: 132, range: 2 - 3770) |
Gleason score (case) | |
6 | 2 |
7 | 3 |
8 - 10 | 6 |
not done | 3 |
Clinical stage at diagnosis (case) | |
B | 3 |
C | 3 |
D | 8 |
Age at alteration (±SD) (years) | 81.4 ± 4.3 |
Duration of agonist (months) | 79.6 ± 63.9 |
PSA before alterarion (ng/mL) | 28.6 ± 35.0 |
PSAV before alteration (ng/mL/year) | 43.3 ± 66.4 |
LH before alteration (mIU/mL) | <0.1 |
FSH before alteration (mIU/mL) | 3.4 ± 2.7 |
Testosterone before alteration (ng/mL) | <0.03 |
PSAV: PSA velocity | Mean ± SD |